CD8A and COVID-19: Nevertheless, observations on patients with mild disease have illustrated a significantly decreased T cell and CD8 levels, indicating a possibility of SARS-CoV-2 directly infecting lymphocytes, which is eventually represented in dysfunctional antiviral effects [14]. Reactivation of HZ is not frequent in COVID-19 patients, but few cases raised the concerns of the possible association.